Latest Breaking News On - Codagenix inc - Page 1 : comparemela.com

The global attenuated vaccines market is expected to expand from US$ 4.45 billion in 2022 to US$ 9.31 billion by 2032 at a compound annual growth rate (CAGR) of 6.8%.Attenuated vaccination helps in preventing ailments like yellow fever, tuberculosis, measles, retroviral, and likewise. Moreover, it has been reported.

United statesNew yorkAstellas pharmaMission indradhanushSerum institute of india pvtIntramuscular attenuated vaccines administrationConsumer technologyCodagenix incSubcutaneous attenuated vaccines administrationGreater new york chamberMarket insights incIntravenous attenuated vaccines administrationOral attenuated vaccines administrationPfizer incRoute of administrationAge group